Meribank Biotech Co., Ltd (TPEX:4724)

Meribank Biotech Revenue

In the year 2025, Meribank Biotech had annual revenue of 471.76M TWD with 28.75% growth. Meribank Biotech had revenue of 221.35M in the half year ending December 31, 2025, with 68.61% growth.

• Revenue: 471.76M
• Revenue Growth: +28.75%
• P/S Ratio: 1.93
• Revenue / Employee: 3.32M
• Employees: 142
• Market Cap: 910.81M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	471.76M	105.33M	28.75%
Dec 31, 2024	366.43M	132.09M	56.37%
Dec 31, 2023	234.34M	54.22M	30.10%
Dec 31, 2022	180.12M	17.04M	10.45%
Dec 31, 2021	163.08M	-31.32M	-16.11%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 19, 2026

Data Sources Report a data error